Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo

Psychopharmacology (Berl). 2007 Apr;191(3):843-53. doi: 10.1007/s00213-007-0733-z. Epub 2007 Feb 16.

Abstract

Rationale: Endocannabinoid-mediated forms of transient synaptic depression have been described in several brain structures, including the dopaminergic ventral tegmental area (VTA). However, their functional and/or behavioural correlates are yet to be determined.

Objectives: The present study was designed to investigate whether back-propagating action potentials in dopamine (DA) neurons, evoked by the stimulation of the medial forebrain bundle (MFB), could trigger endocannabinoid-mediated forms of synaptic modulation. The MFB contains axons ascending from DA neurons to the nucleus accumbens and other forebrain structures, and its stimulation is rewarding because it elicits intra-cranial self-stimulation.

Materials and methods: Single cell extracellular recordings were carried out from anti-dromically identified VTA DA neurons in chloral hydrate anesthetized rats.

Results: DA neurons responded to MFB stimulation (1 s, 20-80 Hz) with a frequency-dependent increase in spontaneous firing rate, which was enhanced by the cannabinoid type-1 receptor antagonist SR141716A (1 mg/kg) and depressed by the agonist WIN55212-2 (0.125 mg/kg). Increasing brain levels of the endocannabinoid anandamide by blocking its major hydrolysing enzyme, fatty-acid amide hydrolase, with URB597 (0.1 mg/kg) was ineffective, whereas blockade of the endocannabinoid membrane transporter with UCM707 (1 mg/kg) enhanced post-stimulus firing rate.

Conclusions: Our study indicates that stimulation of the MFB evokes an endocannabinoid-mediated short-term modulation of DA neuron activity. Thus, endocannabinoids might play an important role in the mechanisms underlying the rewarding properties of MFB stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Animals
  • Arachidonic Acids / pharmacology
  • Behavior, Animal*
  • Benzoxazines / pharmacology
  • Cannabinoid Receptor Modulators / metabolism*
  • Dopamine / metabolism*
  • Electric Stimulation
  • Endocannabinoids*
  • Furans / pharmacology
  • Male
  • Medial Forebrain Bundle / drug effects
  • Medial Forebrain Bundle / metabolism*
  • Membrane Transport Proteins / metabolism
  • Morpholines / pharmacology
  • Motivation
  • Naphthalenes / pharmacology
  • Neurons / metabolism*
  • Piperidines / pharmacology
  • Polyunsaturated Alkamides / pharmacology
  • Pyrazoles / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Cannabinoid, CB1 / metabolism
  • Reward*
  • Rimonabant
  • Self Stimulation
  • Synaptic Transmission*
  • Ventral Tegmental Area / cytology
  • Ventral Tegmental Area / metabolism*

Substances

  • Arachidonic Acids
  • Benzoxazines
  • Cannabinoid Receptor Modulators
  • Endocannabinoids
  • Furans
  • Membrane Transport Proteins
  • Morpholines
  • N-(3-furylmethyl)eicosa-5,8,11,14-tetraenamide
  • Naphthalenes
  • Piperidines
  • Polyunsaturated Alkamides
  • Pyrazoles
  • Receptor, Cannabinoid, CB1
  • (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
  • Rimonabant
  • Dopamine